Paydirt
JS
Insider

Jack W Schuler

Director

Jack W Schuler (Director) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales), most often in Biodesix, Inc. (BDSX). Across 5 priced purchase filings, the average 21-session return was +10.3% from execution and +8.9% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of BDSX (100,000 sh across 2 lots, as filed), executed Jan 23.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
+10.3%
avg across 5 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+8.9%
same 5 filings, from disclosure
Filings, ttm
5
5 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.1M
shares × price, as filed
Last traded
Aug 12
Filed Aug 13

Median ADV $1.8M across their filed names

Impact on $10,000 · 12M
$12,248 (+22.5%)
S&P 500 $11,725 (+17.2%) · 5.2 pts ahead
$13.9k$11.2k$8.5kSep 22 2025Mar 23Sep 21
Jack W Schuler S&P 500

Compounded across filings from disclosure dates · past 12 months

Open performance
Volume by month
$2.1M$1.0M$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2024 · sells $314KSep 2025 · buys $1.5MJan 2026 · buys $2.1MAug 2026 · buys $1.0M
Buys $4.6M Sells $314K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names
BDSX Biodesix, Inc. BDSX · 10 buys · 0 sells 10 filings AWHL AWHL AWHL · 1 buy · 0 sells 1 filing AXDX AXDX AXDX · 0 buys · 1 sell 1 filing
Recent filings
BDSXPURCHASE Biodesix, Inc. View filing → $367K
15,000 sh × $24.47
Exec Aug 12
Filed Aug 13 · 5:22 PM ET
BDSXPURCHASE Biodesix, Inc. View filing → $666K
27,600 sh across 2 lots
Exec Aug 10
Filed Aug 12 · 5:55 PM ET
BDSXPURCHASE Biodesix, Inc. View filing → $1.2M
100,000 sh across 2 lots
Exec Jan 23
Filed Jan 27 · 9:29 AM ET
BDSXPURCHASE Biodesix, Inc. View filing → $904K
82,465 sh × $10.96
Exec Jan 22
Filed Jan 26 · 9:28 AM ET
BDSXPURCHASE Biodesix, Inc. View filing → $1000K
142,045 sh × $7.04
Exec Sep 19 2025
Filed Sep 23 2025 · 9:29 AM ET
AWHLPURCHASE Aspira Women's Health Inc. View filing → $500K
1,111,111 sh × $0.45
Exec Sep 17 2025
Filed Sep 19 2025 · 5:26 PM ET
BDSXPURCHASE Biodesix, Inc. View filing →
3,488,372 sh · price not plausible
Exec Aug 29 2025
Filed Sep 3 2025 · 4:42 PM ET
BDSXPURCHASE Biodesix, Inc. View filing →
4,723,239 sh across 2 lots · price not plausible
Exec May 16 2025
Filed May 20 2025 · 5:30 PM ET
More filings →